Skip to content

Smoking Reduction Intervention for Smokers Not Willing to Quit Smoking: a Randomised Control Trial

Smoking Reduction Intervention for Smokers Not Willing to Quit Smoking: a Randomised Control Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00563329
Enrollment
3826
Registered
2007-11-26
Start date
2004-10-31
Completion date
2006-07-31
Last updated
2013-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking Cessation

Keywords

Smokers who are not willing to quit in the near future but intend to reduce smoking

Brief summary

The aims of this study are (1) to examine the effect of smoking reduction intervention (reduction counseling and nicotine replacement therapy, NRT) (a) on smoking cessation and (b) on reducing daily cigarette consumption among smokers not willing to quit smoking but want to reduce smoking, and (2) to examine the effect of adherence intervention in producing a higher (a) adherence rate, (b) reduction rate, and (c) quit rate.

Interventions

PROCEDUREReduction Intervention + Adherence Intervention
BEHAVIORALReduction Intervention
PROCEDUREcontrol

Sponsors

The University of Hong Kong
CollaboratorOTHER
Hospital Authority, Hong Kong
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Age 18 or above * Ethnic Chinese male or female * Smokes at least 2 cigarettes per day * Have no intention to quit in the near future * Intends to reduce smoking in the next 7 days * Has no contraindication to NRT

Exclusion criteria

* Subjects who are psychologically or physically unable to communicate * Children and teenagers (age below 18) * Pregnant or intention to become pregnant within the next 6 months * Those on regular psychotropic medications and in the presence of any serious health problems that may make them unsuitable for using NRT, such as recent stroke, palpitation, or other life threatening conditions

Design outcomes

Primary

MeasureTime frame
quit rate6 months
Reduction Rate (reduction of cigarette consumption by at least 50% compared with baseline)6 months
Adherence Rate to NRT4 weeks

Secondary

MeasureTime frame
Validated quit rate (by measuring exhaled CO and urinary cotinine level)6 months
Quit rate without validation1 month
self-reported use of NRT for at least 4 weeks or 8 weeks, without cotinine validation1 month / 3 month

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026